Physician
Irwin, Thomas
Irwin, Thomas was paid $100K by Medicaid between Jan 2018 and Apr 2022, across 8 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 35% of everything it billed.
33Billing provider infoIRWIN, THOMAS
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1629172358assigned 09/12/2006
33bProvider typeOtolaryngology Physician
28Total paid$100K
24GClaims1,729
24DCodes billed8
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Otolaryngology Physician providers in Louisiana
Rank by total paid#25 of 56
Median peer was paid$82K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 539 | $25K | |
| 2019 | 465 | $21K | |
| 2020 | 445 | $25K | |
| 2021 | 168 | $7K | |
| 2022 | 112 | $23K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 35% | 632 | 615 | $35K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 921 | 827 | $34K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 20% | 48 | 48 | $20K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.0% | 29 | 18 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.1% | 29 | 18 | $1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | 13 | $900.00 |
| 87486 | <1% | 28 | 18 | $636.13 | |
| 87581 | <1% | 28 | 18 | $636.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.